BAA FY25C3AP15: noninvasive fingerprinting of aluminum-adjuvanted vaccines

Active Definitive Contract Awarded Last action

Contract number
75F40125C00071
Awardee
Awarding agency
Obligated
$1,265,103

Award facts

Contract value 100% obligated
$1,265,103.00 Current and potential, with all options
Completion date 43% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Baltimore, MD 21201, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00002 $773,103
Other Administrative Action P00001 $0
Original award $492,000

About this award

The Food and Drug Administration awarded a definitive contract to University of Maryland, Baltimore for noninvasive fingerprinting of aluminum-adjuvanted vaccines using analytical chemistry methods on September 9, 2025, with a ceiling value of $1.27 million and a firm fixed price structure.

The contract performs through March 29, 2028, at the Baltimore Campus location in Baltimore, MD. The originating solicitation (BAA FY25C3AP15) seeks analytical characterization of vaccine formulations containing aluminum adjuvants. No set-aside applied to this award.

Quick answers

Who was awarded contract 75F40125C00071?

75F40125C00071 was awarded to University Of Maryland, Baltimore by Food and Drug Administration (Department of Health and Human Services) on September 9, 2025.

How much is contract 75F40125C00071 worth?

The government has obligated $1,265,103 on 75F40125C00071.

Was contract 75F40125C00071 competed?

The extent of competition for 75F40125C00071 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award